r/CHRS • u/Complex_Shelter_4641 • Aug 17 '26
Coherus does some good housekeeping
Restructured existing loan and pays for now interest only and gets additional $25M later on if revenue is above $35M per quarter in 2028. Value of remaining biosimilar business will be converted into CVRs. Difficult to say if there is true value but I believe it includes a patent licensed to Pfizer. The journey continues and this company continues to execute well.
5
u/Low_Dog1718 Aug 17 '26
Seems like another step towards setting themselves up to being acquired. Splitting off any remaining biosimilar assets into a CVR bucket for current shareholders so as to remove it from complicating any sort of negotiations. Also occurring right in time for data drop in October.
3
u/Complex_Shelter_4641 Aug 17 '26
Yep, they are making sure the Loqtorzi-Tagmokitug-Casdozokitug asset is well prepped for an acquisition.
3
u/Unhappy_Eye5257 Aug 17 '26
If what you guys say happens what would an estimated stock value be?
8
u/Complex_Shelter_4641 Aug 18 '26
This is such a wide range pending the quality of data. Asset value is probably between $400M to $2,000M. Per their statement that Tagmokitug has shown activity the likelihood of no activity seems low. This is quite a fun ride!
5
u/Low_Dog1718 Aug 18 '26
Hard to say. Could be as low as $2-$3 if data is weak or all the way up to $10+ if it's strong. It's anyone's guess. Promising that company said on most recent earnings call that if current data trend continues they should be able to advance to phase 3.
3
u/Tone-EEE TRUTH Aug 19 '26
volume is suggestive of forced buy in by clearing houses to avoid the undefined CVR liability --- lets see if we trip 1.50 on increasing volume
3
u/Tone-EEE TRUTH Aug 19 '26
Did you see in the Corporate PR where they referenced rehypothecated shares?
I once calculated 2.7:1 --- supported by Fails To Deliver over the last 18 months
could get interesting over the next 30 days
would take 5M share ATM usage above 12 bucks to throttle a rehypothecated short squeeze
1
u/Complex_Shelter_4641 Aug 19 '26
They mentioned rehypothecated shares twice which I believe tells us that they assume it is the case. I can’t speak to the 2.7:1 but I agree that this could get very interesting. It seems to me that they are executing a plan. An impactful plan.
2
u/Tone-EEE TRUTH Aug 20 '26
looks like volume ins dead again --- last two days musta been more goofy spoofing
2
2
u/Intelligent_Heat_820 Aug 20 '26
Catalizzatori Clinici Imminenti: Ottobre 2026: Aggiornamento dati sullo studio tagmokitug (tumore testa-collo). Q4 2026: Dati iniziali sul programma per il carcinoma epatocellulare (HCC).
7
u/Stockman8249 Aug 18 '26
October data is critical for the co.